Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
Globe Newswire•02/11/2026•16:05 ET
0
Key Highlights
- ➤Myriad Genetics to participate in three healthcare investor conferences in November and December 2026
- ➤UBS Global Healthcare Conference fireside chat scheduled for Nov. 10, 2026
- ➤Stephens Investment Conference fireside chat scheduled for Nov. 18, 2026
- ➤Piper Sandler Healthcare Conference fireside chat scheduled for Dec. 2, 2026
SALT LAKE CITY, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that Myriad management will participate in three upcoming healthcare conferences. * The UBS Global Healthcare Conference with a fireside chat on Tuesday, Nov. 10, 2026, at 1:15 pm ET.
* The 2026 Stephens Investment Conference with a fireside chat on Wednesday, Nov. 18, 2026, at 3:00 pm ET.
Get started
Create a free account to read the full story.